Promoting Rational Use of Medicines: Core Components - WHO Policy Perspectives on Medicines, No. 005, September 2002
(2002; 6 pages) [French] [Spanish] Ver el documento en el formato PDF
Índice de contenido
Ver el documentoDefinition of rational use of medicines
Ver el documentoThe problem of irrational use
Ver el documentoAssessing the problem of irrational use
Ver el documentoWorking towards rational use of medicines
Cerrar esta carpetaCore policies to promote more rational use of medicines
Ver el documento1. A mandated multi-disciplinary national body to coordinate medicine use policies
Ver el documento2. Clinical guidelines
Ver el documento3. Essential medicines list based on treatments of choice
Ver el documento4. Drugs and therapeutics committees in districts and hospitals
Ver el documento5. Problem-based training in pharmacotherapy in undergraduate curricula
Ver el documento6. Continuing in-service medical education as a licensure requirement
Ver el documento7. Supervision, audit and feedback
Ver el documento8. Independent medicine information
Ver el documento9. Public education about medicines
Ver el documento10. Avoidance of perverse financial incentives
Ver el documento11. Appropriate and enforced regulation
Ver el documento12. Sufficient government expenditure to ensure availability of medicines and staff
Ver el documentoKey documents
Ver el documentoContacts at WHO Headquarters
 

8. Independent medicine information

Often, the only information about medicines that practitioners receive is provided by the pharmaceutical industry and may be biased. Provision of independent (unbiased) information is therefore essential. Drug information centres (DICs) and drug bulletins are two useful ways to disseminate such information. Both may be run by government or a university teaching hospital or a nongovernmental organization, under the supervision of a trained health professional, Whoever runs the DIC or bulletin must (1) be independent of outside influences and disclose any financial or other conflict of interest, and (2) use evidence-based medicine and transparent deduction for all recommendations made. The WHO Model Formulary provides independent information on all medicines in the WHO Model List of Essential Medicines.

Ir a la sección anterior Ir a la siguiente sección
 

Última actualización: le 3 mayo 2013